Impurity formation studies with peptide-loaded polymeric microspheres: Part I. In vivo evaluation


    loading  Checking for direct PDF access through Ovid

Abstract

The purpose of the present investigation was to assess the peptide related substances or impurities formed during incubation of drug loaded poly-(d,l-lactide-co-glycolide) (PLGA) and poly-(d,l-lactide) (PLA) microspheres under in vivo conditions. Sprague–Dawley rats were injected with separate batches of octreotide microspheres prepared by either an oil/water or oil/oil dispersion technique. At specified time points (days 14, 22, 30, and 41), animals were sacrificed and microsphere particles were recovered from the subcutaneous injection sites. The recovered particles were further extracted with 1:1 mixture of dimethylsulfoxide:dichloromethane for subsequent impurity analysis by HPLC and mass spectrometry. During incubation, the percentage purity of parent compound depended on the PLGA co-monomer ratio (e.g. 50:50, 85:15, and 100:0 glycolide:lactide ratios). After 41 days of incubation, for instance, octreotide area percentage by HPLC was determined to be ∼47% for PLGA 50:50 microspheres, ∼75% for PLGA 85:15 microspheres, and ∼87% for PLA microspheres. Spectral analysis of particle extracts revealed the presence of peptide related substances with 58 m/z and 72 m/z units higher than the parent peptide m/z value. This indicated the presence of glycoyl and lactoyl covalent substitutions on the drug compound, resulting from chemical interaction between peptide amine groups and PLGA or PLA ester groups.

    loading  Loading Related Articles